NDTV-Dettol Banega Swasth Swachh India NDTV-Dettol Banega Swasth Swachh India
  • Home/
  • News/
  • Two Positive Tests At Interval Of 102 Days With One Negative Defined As SARS-CoV-2 Re-Infection: ICMR Study

News

Two Positive Tests At Interval Of 102 Days With One Negative Defined As SARS-CoV-2 Re-Infection: ICMR Study

While COVID-19 re-infection is still rarely reported, nonetheless, immunity should not be assumed and public health measures such as physical distancing, hand-hygiene, and use of masks should be followed after recovery from first event of infection, said ICMR study

Two Positive Tests At Interval Of 102 Days With One -Ve Defined As SARS-CoV-2 Re-Infection: ICMR Study
Highlights
  • SARS-CoV-2 re-infection is still a rare phenomenon but concerning: ICMR
  • ICMR's new study has defined COVID-19 re-infections
  • Re-infections means a person testing positive twice after a gap: ICMR

New Delhi: Two positive tests at an interval of at least 102 days with one interim negative test have been defined as SARS-CoV-2 re-infection by Indian scientists for establishing surveillance systems, according to an ICMR (Indian Council of Medical Research) study. But a confirmation of the re-infection will require a whole genome sequencing, it stated. While SARS-CoV-2 re-infection is still a rare phenomenon, Indian scientists have developed an easy-to-use epidemiological definition of re-infection for establishing surveillance systems.

Also Read: Compromised COVID Appropriate Behaviour Is Single Largest Reason For Cases Upsurge: Dr. Ram Manohar Lohia Hospital’s Director

According to the study ‘SARS-CoV-2 re-infection: development of an epidemiological definition from India’ which has been published by Cambridge in the Epidemiology and Infection journal, an investigation was conducted with the objective to develop an epidemiological case definition of possible SARS CoV-2 re-infection and assess its magnitude in India.

SARS-CoV-2 re-infection is an emerging concern and there is a need to define it, the scientists highlighted. Therefore, working epidemiological case definition for re-infection was developed and its magnitude was explored via archive-based, telephonic survey. The epidemiological case definition for SARS-CoV-2 reinfection was developed from literature review of data on viral kinetics.

Re-infection with SARS CoV-2 was defined as two positive tests at an interval of at least 102 days with one interim negative test. During the archive based, telephonic survey, thirty-eight of the 58 eligible patients could be contacted, with twelve (31.6 per cent) being healthcare workers. Majority of the participants were asymptomatic and had higher Ct value during their first episode.

To conclude, a working epidemiological case definition of SARS CoV-2 re-infection is important to strengthen surveillance. The present investigation contributes to this goal and records reinfection in 4.5 per cent of SARS CoV-2 infected individuals in India, the study stated.

Also Read: Pfizer-BioNTech Say COVID-19 Vaccine Protection Lasts At Least Six Months, Effective Against South African Variant

Taking available evidence into consideration, re-infection with SARS CoV-2 in our study was defined as any individual who tested positive for SARS-CoV-2 on two separate occasions by either molecular tests or rapid antigen test at an interval of at least 102 days with one negative molecular test in between, the study stated.

While SARSCoV-2 re-infection is still a rare phenomenon, there is a need for an epidemiological definition of re-infection for establishing surveillance systems and this study contributes to such goal, it said.

Some respondents in the study had a symptomatic second episode as opposed to the first one. The rate and duration of hospitalisation was not compared as during the initial phase of the pandemic in India all cases were being hospitalized for at least 14 days, irrespective of symptom severity.

Currently, there is no consensus regarding the working definition of re-infection, based only on epidemiological features; a resource intensive method like whole genome sequencing being the only confirmation.

It is not logistically feasible to store the samples of millions of positive cases for future sequencing to identify an important phenomenon like SARS CoV-2 re-infection, the study said.

Also Read: New Portable Test To Diagnose COVID-19 Quickly, Track Variants

Centers for Disease Control and Prevention (CDC) has considered the duration of 90 days between two positive SARS-CoV-2 RNA along with genomic evidence of re-infection as an investigative criterion to understand the phenomenon of reinfection. Both CDC and European CDC suggested the use of genomic evidence for confirmation of reinfection, However, an epidemiological working definition will be more pragmatic and helpful to assess the magnitude of re-infection in most population and resource constrained settings.

While COVID-19 re-infection is still rarely reported, nonetheless, immunity should not be assumed and public health measures such as physical distancing, hand-hygiene, and use of masks should be followed after recovery from first event of infection, the study stated.

Further well-designed cohort studies must be undertaken to understand the natural history of COVID-19, including its immunogenicity, susceptibility to re-infection, antibody dependent enhancement and the severity of re-infections. It may also be suggested that the samples of healthcare workers may be stored for genomic analysis to study suspected COVID-19 reinfections, particularly in resource limited settings as chances of them encountering such events are higher due to potential high-risk occupational exposure.

Also Read: Administer 5-10 Million COVID Vaccine Doses Per Day, Do Genomic Surveillance For Variants: Expert On COVID In India

(Except for the headline, this story has not been edited by NDTV staff and is published from a syndicated feed.)

NDTV – Dettol Banega Swasth India campaign is an extension of the five-year-old Banega Swachh India initiative helmed by Campaign Ambassador Amitabh Bachchan. It aims to spread awareness about critical health issues facing the country. In wake of the current COVID-19 pandemic, the need for WASH (WaterSanitation and Hygiene) is reaffirmed as handwashing is one of the ways to prevent Coronavirus infection and other diseases. The campaign highlights the importance of nutrition and healthcare for women and children to prevent maternal and child mortality, fight malnutrition, stunting, wasting, anaemia and disease prevention through vaccines. Importance of programmes like Public Distribution System (PDS), Mid-day Meal Scheme, POSHAN Abhiyan and the role of Aganwadis and ASHA workers are also covered. Only a Swachh or clean India where toilets are used and open defecation free (ODF) status achieved as part of the Swachh Bharat Abhiyan launched by Prime Minister Narendra Modi in 2014, can eradicate diseases like diahorrea and become a Swasth or healthy India. The campaign will continue to cover issues like air pollutionwaste managementplastic banmanual scavenging and sanitation workers and menstrual hygiene

[corona_data_new]
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Highlights: Banega Swasth India Launches Season 10

Reckitt’s Commitment To A Better Future

India’s Unsung Heroes

Women’s Health

हिंदी में पढ़ें

This website follows the DNPA Code of Ethics

© Copyright NDTV Convergence Limited 2024. All rights reserved.